メソイオン化合物
Senff-Ribeiro, A; Echevarria, A; Silva, EF; Franco, CR; Veiga, SS; Oliveira, MB (2004). “Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma”. British journal of cancer 91 (2): 297–304. doi:10.1038/sj.bjc.6601946. PMC 2409799. PMID 15199390. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409799/.
Mickleburgh, I; Geng, F; Tiley, L (2009). “Mesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activity”. Antiviral chemistry & chemotherapy 19 (5): 213–8. PMID 19483269.
Cadena, Silvia M.S.C.; Carnieri, Eva G.S.; Echevarria, Aurea; De Oliveira, Maria Benigna Martinelli (2002).
“Interference of MI-D, a new mesoionic compound, on artificial and native membranes”. Cell Biochemistry and Function 20 (1): 31–7. doi:10.1002/cbf.932. PMID 11835268.
Papageorgiou, M.; Kokkou, S. C.; Rentzeperis, P. J.; Tsoleridis, C. (1983). “Structure of the mesoionic compound N-[1-methyl-3-(p-tolyl)-4-(1,2,3-triazolio)]acetamidate (MMTAT), C12H14N4O”. Acta Crystallographica Section C Crystal Structure Communications 39 (11): 1581. doi:10.1107/S0108270183009348.
Potts, K. T.; Husain, Syeda (1971). “Mesoionic compounds. XIV. Mesoionic compounds of the imidazole series”. The Journal of Organic Chemistry 36 (22): 3368. doi:10.1021/jo00821a022.